Genmab A/S (GEN.CO) Release: Daratumumab Data to be Presented at American Society of Clinical Oncology Annual Meeting
5/16/2013 10:04:47 AM
More...
|
FDA Grants Breakthrough Status to Johnson & Johnson (JNJ), Genmab A/S (GEN.CO) Cancer Drug
5/1/2013 11:32:26 AM
More...
|
Genmab A/S (GEN.CO) and GlaxoSmithKline (GSK)'s Arzerra Receives Approval in Japan
3/25/2013 7:23:20 AM
More...
|
Genmab A/S (GEN.CO) Summons Annual General Meeting
3/19/2013 11:16:33 AM
More...
|
Genmab A/S (GEN.CO) Rises as Danske Sees FDA Breakthrough
2/15/2013 7:36:25 AM
More...
|
Genmab A/S (GEN.CO) to Present at the 31st Annual J.P. Morgan Healthcare Conference
1/3/2013 9:07:13 AM
More...
|
Genmab A/S (GEN.CO) Unveils A New Antibody Technology Platform: HexaBody
12/17/2012 9:15:40 AM
More...
|
Genmab A/S (GEN.CO) Reduces Fair Value of Minnesota Manufacturing Facility to Zero, Moves Sale into 2013 and Updates 2012 Guidance
12/14/2012 10:01:55 AM
More...
|
Genmab A/S (GEN.CO) Reaches Third Milestone in H. Lundbeck A/S (LUN.CO) Collaboration
12/13/2012 9:51:41 AM
More...
|
Genmab A/S (GEN.CO) Reaches Milestone in DuoBody Platform Collaboration With Janssen Biotech Inc.
12/11/2012 9:37:10 AM
More...
|
|